![]()
Taiwan Semiconductor Manufacturing, Applied Materials, and Astrazeneca are the three Manufacturing stocks to watch today, according to MarketBeat’s stock screener tool. Manufacturing stocks are equity shares of companies whose primary business is producing physical goods—such as autos, machinery, electronics, chemicals, and consumer durables—rather than providing services. For investors, these stocks are often cyclical and sensitive to economic growth, industrial indicators (like PMI and industrial production), commodity prices, and capital spending, which can drive their revenue and profit volatility. These companies had the highest dollar trading volume of any Manufacturing stocks within the last several days.
Taiwan Semiconductor Manufacturing (TSM)
Taiwan Semiconductor Manufacturing Company Limited, together with its subsidiaries, manufactures, packages, tests, and sells integrated circuits and other semiconductor devices in Taiwan, China, Europe, the Middle East, Africa, Japan, the United States, and internationally. It provides a range of wafer fabrication processes, including processes to manufacture complementary metal- oxide-semiconductor (CMOS) logic, mixed-signal, radio frequency, embedded memory, bipolar CMOS mixed-signal, and others.
Applied Materials (AMAT)
Applied Materials, Inc. engages in the provision of manufacturing equipment, services, and software to the semiconductor, display, and related industries. The company operates through three segments: Semiconductor Systems, Applied Global Services, and Display and Adjacent Markets. The Semiconductor Systems segment develops, manufactures, and sells various manufacturing equipment that is used to fabricate semiconductor chips or integrated circuits.
Read Our Latest Research Report on AMAT
Astrazeneca (AZN)
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases.
Read Our Latest Research Report on AZN
Recommended Stories
- MarketBeat’s Top Five Stocks to Own in April 2026
- Domino’s Pizza: Outlook for the Berkshire Holding After Q1 Drop
- Why Palantir Suddenly Looks Vulnerable After Google’s Move
- Why Smart Money Is Quietly Piling Into This Lithium Stock
- Corning Beats Q1 Estimates but Drops 9% on Guidance Miss
- Amkor Technology Fires Buy Signal After Q1 2026 Earnings Beat
